Taichung, Taiwan

Ling-Chu Chang

USPTO Granted Patents = 3 


 

Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2016-2020

where 'Filed Patents' based on already Granted Patents

3 patents (USPTO):

Title: Ling-Chu Chang: Innovator in Anticancer Research

Introduction

Ling-Chu Chang is a prominent inventor based in Taichung, Taiwan. He has made significant contributions to the field of anticancer research, holding a total of 3 patents. His work focuses on developing novel compounds that show promise in treating various types of cancer.

Latest Patents

One of his latest patents involves derivatives of curcuminoids and their use as anticancer agents. This series of novel bis(hydroxymethyl) alkanoate derivatives of curcuminoids has demonstrated anticancer activity, particularly against breast cancer, colon cancer, and prostate cancer. Another notable patent relates to novel 20-sulfonylamidine derivatives of camptothecin, which includes methods of synthesizing these compounds and their application as antitumor agents for treating nasopharyngeal, lung, breast, or prostate cancer.

Career Highlights

Ling-Chu Chang has worked with esteemed institutions such as China Medical University and China Medical University Hospital. His research has significantly advanced the understanding and treatment of cancer through innovative chemical compounds.

Collaborations

He has collaborated with notable colleagues, including Sheng-Chu Kuo and Min-Tsang Hsieh, contributing to a rich environment of research and development in the field of oncology.

Conclusion

Ling-Chu Chang's innovative work in anticancer research highlights his commitment to improving cancer treatment options. His patents reflect a dedication to scientific advancement and the potential to save lives through effective therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…